IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma
<p>Treatment with immune checkpoint blockade (ICB) frequently triggers immune-related adverse events (irAEs), causing considerable morbidity. In 214 patients receiving ICB for melanoma, we observed increased severe irAE risk in minor allele carriers of rs16906115, intronic to <em&g...
Main Authors: | Taylor, CA, Watson, RA, Tong, O, Ye, W, Nassiri, I, Gilchrist, JJ, de Los Aires, AV, Sharma, PK, Koturan, S, Cooper, RA, Woodcock, VK, Jungkurth, E, Shine, B, Coupe, N, Payne, MJ, Church, DN, Naranbhai, V, Groha, S, Emery, P, Mankia, K, Freedman, ML, Choueiri, TK, Middleton, MR, Gusev, A, Fairfax, BP |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Springer Nature
2022
|
Similar Items
-
Natural Killer cells demonstrate distinct eQTL and transcriptome-wide disease associations, highlighting their role in autoimmunity
by: Gilchrist, JJ, et al.
Published: (2022) -
Immune checkpoint blockade sensitivity and progression-free survival associates with baseline CD8+ T cell clone size and cytotoxicity
by: Watson, RA, et al.
Published: (2021) -
Distinct transcriptional and anti-mycobacterial profiles of peripheral blood monocytes dependent on the ratio of monocytes: lymphocytes
by: Naranbhai, V, et al.
Published: (2015) -
Weak integrability breaking and full counting statistics
by: Groha, S
Published: (2018) -
Identification of neutralising pembrolizumab anti-drug antibodies in patients with melanoma
by: Sasson, SC, et al.
Published: (2021)